Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Long Alison S Insider Profile
4 Followers
Long Alison S, CMO at Kaleido Biosciences, holds ― shares in Kaleido Biosciences (Ticker: KLDO), holds 49.22K shares in Taysha Gene Therapies (Ticker: TSHA). Most recently, Long Alison S ― shares of Kaleido Biosciences on ― for an estimated value of ―.
Long Alison S has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Long Alison S holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Long Alison S
Long Alison S's Trading History
Kaleido Biosciences
―
CMO
―
―
Taysha Gene Therapies
May 31, 2024
Director
Uninformative Buy
―
$112.71K
List of latest transactions for each holding click on a transaction to see Long Alison S's performance on stock
You May Also Like
Long Alison S insider profile FAQ
What is the percentage of profitable transactions made by Long Alison S?
The percentage of profitable transactions made by Long Alison S is ―.
What is the average return per transaction made by Long Alison S?
The average return per transaction made by Long Alison S is ―.
What stocks does Long Alison S hold?
Long Alison S holds: KLDO, TSHA stocks.
What was Long Alison S’s latest transaction?
Long Alison S latest transaction was an Uninformative Buy of ―.
What was Long Alison S's most profitable transaction?
Long Alison S’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Long Alison S's role in Kaleido Biosciences?
Long Alison S's role in Kaleido Biosciences is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.